YU105083A - Process for obtaining quinazoline cardiac stimulants - Google Patents
Process for obtaining quinazoline cardiac stimulantsInfo
- Publication number
- YU105083A YU105083A YU01050/83A YU105083A YU105083A YU 105083 A YU105083 A YU 105083A YU 01050/83 A YU01050/83 A YU 01050/83A YU 105083 A YU105083 A YU 105083A YU 105083 A YU105083 A YU 105083A
- Authority
- YU
- Yugoslavia
- Prior art keywords
- cardiac stimulants
- quinazoline
- obtaining
- obtaining quinazoline
- stimulants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8214206 | 1982-05-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| YU105083A true YU105083A (en) | 1986-02-28 |
Family
ID=10530384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| YU01050/83A YU105083A (en) | 1982-05-15 | 1983-05-12 | Process for obtaining quinazoline cardiac stimulants |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4489075A (xx) |
| EP (1) | EP0094766B1 (xx) |
| JP (1) | JPS58208289A (xx) |
| KR (1) | KR840004747A (xx) |
| AU (1) | AU538171B2 (xx) |
| CA (1) | CA1195977A (xx) |
| DD (2) | DD210269A5 (xx) |
| DE (1) | DE3368631D1 (xx) |
| DK (1) | DK210183A (xx) |
| ES (3) | ES522278A0 (xx) |
| FI (1) | FI831684L (xx) |
| GR (1) | GR77498B (xx) |
| IL (1) | IL68668A0 (xx) |
| IN (1) | IN160680B (xx) |
| NO (1) | NO831728L (xx) |
| NZ (1) | NZ204225A (xx) |
| PH (1) | PH18763A (xx) |
| PL (2) | PL247054A1 (xx) |
| PT (1) | PT76687B (xx) |
| SU (1) | SU1194257A3 (xx) |
| YU (1) | YU105083A (xx) |
| ZA (1) | ZA833422B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8320958D0 (en) * | 1983-08-03 | 1983-09-07 | Pfizer Ltd | Quinazoline cardiac stimulants |
| JPS61215389A (ja) * | 1985-03-20 | 1986-09-25 | Kyowa Hakko Kogyo Co Ltd | キナゾリン誘導体およびそれを含有する強心剤 |
| US5138062A (en) * | 1989-10-03 | 1992-08-11 | Philip Morris Incorporated | Nicotine analogs |
| ATE231505T1 (de) * | 1991-03-28 | 2003-02-15 | Eisai Co Ltd | Neue heterocyclische/cyclische amine |
| MX371014B (es) * | 2014-05-15 | 2020-01-10 | Pfizer | Forma cristalina de 6-[(4r)-4-metil-1,2-dióxido-1,2,6-tiadiazinan- 2-il]isoquinolin-1-carbonitrilo. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3971783A (en) * | 1973-03-07 | 1976-07-27 | Pfizer Inc. | 4-Aminoquinazoline derivatives as cardiac stimulants |
| GB1460389A (en) * | 1974-07-25 | 1977-01-06 | Pfizer Ltd | 4-substituted quinazoline cardiac stimulants |
| US4171363A (en) * | 1977-02-22 | 1979-10-16 | Bristol-Myers Company | 1,2,3-Thiadiazole process |
| CA1086735A (en) * | 1977-11-03 | 1980-09-30 | John C. Danilewicz | Piperidino-quinazolines |
-
1983
- 1983-04-27 US US06/489,271 patent/US4489075A/en not_active Expired - Fee Related
- 1983-05-05 EP EP83302529A patent/EP0094766B1/en not_active Expired
- 1983-05-05 DE DE8383302529T patent/DE3368631D1/de not_active Expired
- 1983-05-10 IN IN297/DEL/83A patent/IN160680B/en unknown
- 1983-05-11 DK DK210183A patent/DK210183A/da not_active Application Discontinuation
- 1983-05-11 ES ES522278A patent/ES522278A0/es active Granted
- 1983-05-12 IL IL68668A patent/IL68668A0/xx unknown
- 1983-05-12 YU YU01050/83A patent/YU105083A/xx unknown
- 1983-05-13 GR GR71346A patent/GR77498B/el unknown
- 1983-05-13 CA CA000428080A patent/CA1195977A/en not_active Expired
- 1983-05-13 NZ NZ204225A patent/NZ204225A/en unknown
- 1983-05-13 PH PH28901A patent/PH18763A/en unknown
- 1983-05-13 FI FI831684A patent/FI831684L/fi not_active Application Discontinuation
- 1983-05-13 NO NO831728A patent/NO831728L/no unknown
- 1983-05-13 PL PL24705483A patent/PL247054A1/xx unknown
- 1983-05-13 DD DD83250918A patent/DD210269A5/de unknown
- 1983-05-13 PL PL24196883A patent/PL241968A1/xx unknown
- 1983-05-13 SU SU833597905A patent/SU1194257A3/ru active
- 1983-05-13 DD DD83259680A patent/DD216018A5/de unknown
- 1983-05-13 ZA ZA833422A patent/ZA833422B/xx unknown
- 1983-05-13 AU AU14522/83A patent/AU538171B2/en not_active Ceased
- 1983-05-13 PT PT76687A patent/PT76687B/pt unknown
- 1983-05-14 KR KR1019830002145A patent/KR840004747A/ko not_active Application Discontinuation
- 1983-05-16 JP JP58085660A patent/JPS58208289A/ja active Pending
- 1983-12-28 ES ES528481A patent/ES528481A0/es active Granted
- 1983-12-28 ES ES528482A patent/ES528482A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| FI831684A0 (fi) | 1983-05-13 |
| SU1194257A3 (ru) | 1985-11-23 |
| IL68668A0 (en) | 1983-09-30 |
| EP0094766A2 (en) | 1983-11-23 |
| ES8504793A1 (es) | 1985-05-01 |
| EP0094766A3 (en) | 1984-12-12 |
| ES8504794A1 (es) | 1985-05-01 |
| NO831728L (no) | 1983-11-16 |
| DD210269A5 (de) | 1984-06-06 |
| ES528482A0 (es) | 1985-05-01 |
| NZ204225A (en) | 1985-12-13 |
| EP0094766B1 (en) | 1986-12-30 |
| AU1452283A (en) | 1983-11-17 |
| DD216018A5 (de) | 1984-11-28 |
| PT76687A (en) | 1983-06-01 |
| GR77498B (xx) | 1984-09-24 |
| DE3368631D1 (de) | 1987-02-05 |
| ES8407039A1 (es) | 1984-08-16 |
| IN160680B (xx) | 1987-07-25 |
| PL241968A1 (en) | 1984-08-13 |
| DK210183D0 (da) | 1983-05-11 |
| DK210183A (da) | 1983-11-16 |
| FI831684L (fi) | 1983-11-16 |
| JPS58208289A (ja) | 1983-12-03 |
| KR840004747A (ko) | 1984-10-24 |
| AU538171B2 (en) | 1984-08-02 |
| PH18763A (en) | 1985-09-20 |
| ES522278A0 (es) | 1984-08-16 |
| CA1195977A (en) | 1985-10-29 |
| PL247054A1 (en) | 1985-03-26 |
| ZA833422B (en) | 1984-02-29 |
| ES528481A0 (es) | 1985-05-01 |
| PT76687B (en) | 1986-03-27 |
| US4489075A (en) | 1984-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT74526B (en) | Process for the preparation of new n-acyl-polypeptides | |
| YU194982A (en) | Process for preparing new benzoheterocycles | |
| CY1470A (en) | Process for the preparation of phenylalkylaminoethylsalicylamide | |
| PT79001A (en) | Process for preparing quinazoline cardiac stimulants | |
| YU43554B (en) | Process for obtaining new platinum-(ii)-diaminic complex | |
| PT83810A (en) | Process for preparing quinolone cardiac stimulants | |
| YU43822B (en) | Process for obtaining new cephalosporinic derivatives | |
| PT82702A (en) | Process for preparing tetrahydroimidazoquinazolinone cardiac stimulants | |
| YU105083A (en) | Process for obtaining quinazoline cardiac stimulants | |
| YU237183A (en) | Process for obtaining new spiro-3-hetero azolines | |
| DE3378370D1 (en) | Process for preparing polycaprolactone | |
| YU44758B (en) | Process for obtaining new phenothiazino derivatives | |
| GB2084121B (en) | Preparing titanium compounds | |
| DE3360384D1 (en) | Process for the preparation of 1-hydroxyketones | |
| YU45150B (en) | Process for obtaining substituted 1-pyridiloxi-3-indolylalkylamino-2-propanole | |
| PT85536A (en) | Process for preparing quinolone cardiac stimulants | |
| YU169783A (en) | Process for obtaining new 28-methyl-brassionosteroid derivatives | |
| DE3171901D1 (en) | Process for the preparation of amino-fluor-s-triazine dyestuffs | |
| GB2055779B (en) | Preparing titanium compounds | |
| YU65979A (en) | Process for obtaining quinazoline | |
| JPS55104368A (en) | Electroplating method | |
| YU43419B (en) | Process for obtaining new izoquinolinic derivatives | |
| YU44867B (en) | Process for obtaining sorbinyle | |
| YU44694B (en) | Process for obtaining substituted ethandiimidamides | |
| YU224886A (en) | Process for obtaining substituted 1-pyridiloxi-3-indolylalkylamino-2-propanole |